Cargando…

Model-Based Analysis of Costs and Outcomes of Non-Invasive Prenatal Testing for Down’s Syndrome Using Cell Free Fetal DNA in the UK National Health Service

BACKGROUND: Non-invasive prenatal testing (NIPT) for Down’s syndrome (DS) using cell free fetal DNA in maternal blood has the potential to dramatically alter the way prenatal screening and diagnosis is delivered. Before NIPT can be implemented into routine practice, information is required on its co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morris, Stephen, Karlsen, Saffron, Chung, Nancy, Hill, Melissa, Chitty, Lyn S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979704/ https://www.ncbi.nlm.nih.gov/pubmed/24714162 http://dx.doi.org/10.1371/journal.pone.0093559

Ejemplares similares

Offering non‐invasive prenatal testing as part of routine clinical service. Can high levels of informed choice be maintained?
por: Lewis, Celine, et al.
Publicado: (2017)

Non‐invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways
por: Verhoef, Talitha I., et al.
Publicado: (2016)

Women’s Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study
por: Lewis, Celine, et al.
Publicado: (2016)

Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta‐analysis
por: Mellis, Rhiannon, et al.
Publicado: (2022)

Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield
por: Barrett, Angela N., et al.
Publicado: (2011)

Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women
por: Oxenford, Kerry, et al.
Publicado: (2013)

Development and evaluation of training resources to prepare health professionals for counselling pregnant women about non-invasive prenatal testing for Down syndrome: a mixed methods study
por: Oxenford, Kerry, et al.
Publicado: (2017)

Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?
por: Hill, Melissa, et al.
Publicado: (2017)

A qualitative study looking at informed choice in the context of non‐invasive prenatal testing for aneuploidy
por: Lewis, Celine, et al.
Publicado: (2016)

Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA
por: Chitty, Lyn S, et al.
Publicado: (2013)

Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis
por: Hill, Melissa, et al.
Publicado: (2015)

Preferences for prenatal diagnosis of sickle‐cell disorder: A discrete choice experiment comparing potential service users and health‐care providers
por: Hill, Melissa, et al.
Publicado: (2017)

Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy
por: Lewis, Celine, et al.
Publicado: (2016)

Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
por: Chitty, Lyn S, et al.
Publicado: (2016)

Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders
por: Hanson, Britt, et al.
Publicado: (2022)

Implementing a rapid fetal exome sequencing service: What do parents and health professionals think?
por: Mellis, Rhiannon, et al.
Publicado: (2022)

Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals
por: Hill, Melissa, et al.
Publicado: (2014)

Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta
por: Hill, Melissa, et al.
Publicado: (2019)

Couples experiences of receiving uncertain results following prenatal microarray or exome sequencing: A mixed‐methods systematic review
por: Harding, Eleanor, et al.
Publicado: (2020)

Cell‐free fetal DNA: the new tool in fetal medicine
por: Everett, T. R., et al.
Publicado: (2015)

RAPIDR: an analysis package for non-invasive prenatal testing of aneuploidy
por: Lo, Kitty K., et al.
Publicado: (2014)

The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis
por: Bayón, J. C., et al.
Publicado: (2019)

Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol
por: Hill, Melissa, et al.
Publicado: (2014)

What's out there for parents? A systematic review of online information about prenatal microarray and exome sequencing
por: Peter, Michelle, et al.
Publicado: (2021)

Evaluation of a Novel Assay for Detection of the Fetal Marker RASSF1A: Facilitating Improved Diagnostic Reliability of Noninvasive Prenatal Diagnosis
por: White, Helen E., et al.
Publicado: (2012)

Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service
por: Hill, Melissa, et al.
Publicado: (2022)

‘Putting salt on the wound’: a qualitative study of the impact of FGM-safeguarding in healthcare settings on people with a British Somali heritage living in Bristol, UK
por: Karlsen, Saffron, et al.
Publicado: (2020)

Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use?
por: Karampetsou, Evangelia, et al.
Publicado: (2014)

Lessons learnt from prenatal exome sequencing
por: Chandler, Natalie J., et al.
Publicado: (2022)

Understanding ethnic inequalities in mental healthcare in the UK: A meta-ethnography
por: Bansal, Narinder, et al.
Publicado: (2022)

Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013)

Available evidence suggests that prevalence and risk of female genital cutting/mutilation in the UK is much lower than widely presumed - policies based on exaggerated estimates are harmful to girls and women from affected communities
por: Karlsen, Saffron, et al.
Publicado: (2022)

Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis
por: Fairbrother, Genevieve, et al.
Publicado: (2016)

Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD
por: Clausen, Frederik Banch, et al.
Publicado: (2013)

Performance of non-invasive prenatal testing when fetal cell-free DNA is absent
por: Takoudes, T, et al.
Publicado: (2015)

Staying “One Step Ahead of a Racist”: Expanding Understandings of the Experiences of the Covid-19 Pandemic Among People From Minoritized Ethnic Groups Living in Britain
por: Karlsen, Saffron, et al.
Publicado: (2021)

Cell-free fetal DNA testing and its correlation with prenatal indications
por: Wang, Jing-wei, et al.
Publicado: (2021)

Health professionals’ and coroners’ views on less invasive perinatal and paediatric autopsy: a qualitative study
por: Lewis, Celine, et al.
Publicado: (2018)

Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach
por: Chitty, Lyn S, et al.
Publicado: (2015)

Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma
por: Ahmadi, Mohammad Hossein, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8vgvbemlkv44sja2ga59lgajtj